Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$30.02
At close: May 15 EDT
$30.02
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Kymera Therapeutics (KYMR) Forecast
NewsEarningsKymera Therapeutics (KYMR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Kymera Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KYMR | Benzinga
Explore Kymera Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KYMR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kymera Therapeutics (KYMR) stock?
You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.
Who are Kymera Therapeutics (KYMR) competitors?
Other companies in Kymera Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?
Kymera Therapeutics has a consensus price target of $51.12.
What is the current price for Kymera Therapeutics (KYMR)?
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $30.02 last updated May 15, 2025 at 4:00 PM EDT.
Does Kymera Therapeutics (KYMR) pay a dividend?
There are no upcoming dividends for Kymera Therapeutics.
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
Kymera Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
Is Kymera Therapeutics (KYMR) going to split?
There is no upcoming split for Kymera Therapeutics.
What sector and industry does Kymera Therapeutics (KYMR) operate in?
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
